Aptadir Therapeutics - Crunchbase Company Profile & Funding

Q: Where is Aptadir Therapeutics's headquarters?

Aptadir Therapeutics is located in Milan, Lombardia, Italy.

Q: Who invested in Aptadir Therapeutics?

Aptadir Therapeutics has 3 investors including Evotec And Angelini Ventures.

Q: How much funding has Aptadir Therapeutics raised to date?

Aptadir Therapeutics has raised obfuscated.

Overview

Aptadir Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Aptadir Therapeutics

CB Rank

108156

Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.

Founded

obfuscation

Private

Pre-Seed

Milan, Lombardia, Italy

1-10

aptadir.com

Biotechnology

Health Care

Medical

Funding Rounds

Pre-Seed

OBF

obfuscation

Key People

Giovanni Amabile: CEO & Executive Chairman
Marcin Kortylewski: Founder

Details

Legal Name

AptaDir therapeutics srl.

Also Known As

Aptadir

Operating Status

Active

Company Type

For Profit

Founders

Annalisa Di Ruscio, Daniel G. Tenen, Marcin Kortylewski, Vittorio de Franciscis

About the Company

Aptadir Therapeutics is developing RNA inhibitor-based therapeutics for treating intractable cancers and genetic conditions.

Contact Email

info@aptadir.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

RNA-based Platform for DNMT1 Inhibition

A platform utilizing specific RNAs to inhibit DNMT1, aiming to alter DNA methylation and gene expression for cancer and rare disease treatment.

aptaDiR

Modified short RNA oligonucleotides designed for global DNMT1 inhibition without cell toxicity.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed
obfuscated obfuscation	Pre Seed Round - Aptadir Therapeutics	3	obfuscated obfuscation	CDP Venture Capital	Pre-Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Evotec	—	Pre Seed Round - Aptadir Therapeutics	—
Evotec	—	Pre Seed Round - Aptadir Therapeutics	—
Evotec	—	Pre Seed Round - Aptadir Therapeutics	—
Evotec	—	Pre Seed Round - Aptadir Therapeutics	—
Evotec	—	Pre Seed Round - Aptadir Therapeutics	—